Amoy Diagnostics Co., Ltd. (SHE:300685)
China · Delayed Price · Currency is CNY 19.58
-0.72 (-3.55%)
Oct 12, 2026, 2:55 PM CST
Amoy Diagnostics Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 1,178 | 1,198 | 1,109 | 1,044 | 842.18 | 917.03 |
Revenue Growth | 2.83% | 8.01% | 6.27% | 23.91% | -8.16% | 25.90% |
Gross Profit Gross Profit Growth | 961.62 | 978.54 | 927.61 | 866.58 | 688.74 | 769.84 |
Operating Income Operating Income Growth | 394.25 | 385.68 | 277.25 | 269.46 | 143.64 | 235.05 |
Net Income Net Income Growth | 338.34 | 361.26 | 254.86 | 261.48 | 263.74 | 239.57 |
Earnings Per Share EPS Growth | 0.84 | 0.90 | 0.64 | 0.66 | 0.67 | 0.60 |
EPS Growth | 10.83% | 40.63% | -3.03% | -1.49% | 11.67% | 33.33% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Testing Reagent Business Testing Reagent Business Growth | 951.89 | 876.85 | 859.88 | 611.39 | 699.04 |
Testing Service Business Testing Service Business Growth | 77.31 | 66.56 | 84.94 | 135 | 154.91 |
Drug Clinical Research Services Drug Clinical Research Services Growth | 158.14 | 160.9 | 88.71 | 86.04 | 54.18 |
Unallocated Other Operations Unallocated Other Operations Growth | 10.39 | 4.64 | 9.99 | 9.75 | 8.91 |
Total Total Growth | 1,198 | 1,109 | 1,044 | 842.18 | 917.03 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 1,226 | 1,342 | 1,181 | 1,022 | 753.98 | 718.73 |
Total Debt Total Debt Growth | 196.73 | 108.6 | 57.26 | 56.68 | 53.64 | 6.06 |
Net Cash (Debt) Net Cash Growth | 1,029 | 1,233 | 1,124 | 965.23 | 700.34 | 712.67 |
Net Cash Growth | -10.47% | 9.77% | 16.40% | 37.82% | -1.73% | 6.94% |
Net Cash Per Share Net Cash Per Share Growth | 2.56 | 3.07 | 2.82 | 2.44 | 1.78 | 1.78 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 388.95 | 364.82 | 341.85 | 298.72 | 149.04 | 168.16 |
Capital Expenditures CapEx Growth | -60.49 | -70.23 | -40.21 | -44.87 | -78.29 | -74.55 |
Free Cash Flow Free Cash Flow Growth | 328.46 | 294.6 | 301.64 | 253.85 | 70.75 | 93.61 |
Free Cash Flow Growth | 2.40% | -2.33% | 18.82% | 258.79% | -24.42% | -42.50% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 81.65% | 81.70% | 83.65% | 83.05% | 81.78% | 83.95% |
Operating Margin | 33.48% | 32.20% | 25.00% | 25.82% | 17.06% | 25.63% |
Pretax Margin | 32.10% | 34.31% | 26.14% | 28.26% | 33.97% | 27.48% |
Profit Margin | 28.73% | 30.16% | 22.98% | 25.06% | 31.32% | 26.13% |
FCF Margin | 27.89% | 24.60% | 27.20% | 24.33% | 8.40% | 10.21% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.450 | 0.450 | 0.300 | 0.150 | 0.140 | 0.128 |
Dividend Per Share Growth | 50.00% | 50.00% | 100.00% | 7.14% | 9.55% | -7.99% |
Dividend Yield | 2.30% | 2.25% | 1.37% | 0.71% | 0.56% | 0.32% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 24.13 | 21.91 | 35.23 | 33.17 | 39.93 | 69.88 |
Forward PE | 20.71 | 23.52 | 26.07 | 32.48 | 48.14 | 66.37 |
P/FCF Ratio | 23.58 | 26.87 | 29.76 | 34.17 | 148.85 | 178.84 |
PS Ratio | 6.58 | 6.61 | 8.10 | 8.31 | 12.51 | 18.26 |